The dramatic increase of intervertebral disc degeneration (IDD) is considered to be a major cause of discogenic low back pain. The current study focused on the regulatory function of PGE2). Through a further study of the molecular mechanism, miR-194 was proved to be involved in the regulation of TRAF6 and its downstream signal molecule, nuclear factor-kappa B (NF-kB).
Background
Intervertebral disc degeneration (IDD) is a widely recognized clinical characteristic of chronic low back pain, and is a secondary symptom and characteristic of lumbar disc herniation, spinal stenosis, and spinal deformity [1] . IDD is considered as a global health burden with severe healthcare and socioeconomic consequences, but its pathogenesis remains obscure. With age, intervertebral disc (IVD) will degenerate naturally, and studies have suggested that the degenerative process is accelerated or aggravated by environmental effects and genetic factors [2, 3] .
Aggrecan is the main proteoglycan in nucleus pulposus (NP) cells, which play a crucial role in the maintenance of IVD height and anti-compression pressure [4] . Collagen II is the major component of fibers in NP cells. Imbalance between anabolic and catabolic gene expression in chondrocytes of NP can result in the occurrence of IDD [5] . Upregulation of some proinflammatory cytokines and extracellular matrix (ECM)-degrading enzymes leads to the homeostasis of catabolism and anabolism in the ECM of IVD, shifting toward a degenerative and catabolic state, and finally causes the breakdown of ECM components, which includes collagen and proteoglycans (PGs) [6, 7] . For instance, TIMP3 is an inhibitor of aggrecanase, whose expression is negatively associated with the severity of IDD, and the imbalance between TIMP3 and aggrecanase can have an adverse effect on IVD [8] .
Moreover, many inflammatory cytokines, including Interleukin1b (IL-1b), IL-6, and IL10, and tissue necrosis factor-a (TNF-a), are also involved in the pathogenesis of IDD. Unlike MMPs or ADAMTSs, these inflammatory cytokines aggravate IDD by inducing inflammatory substances instead of degrading ECM of IVD directly. Lipopolysaccharide (LPS) has been identified as an inflammatory mediator that engages in the process of IDD. LPS is capable of inducing variety of proinflammatory cytokines and matrix-degrading enzymes (including MMP-3, MMP-13, ADAMTS-4, and ADAMTS-5), further decreasing PGs content and promoting the occurrence of IDD [9, 10] .
MicroRNAs (miRNAs) are a type of small noncoding RNA that can bind to target genes through special sequences to repress gene expression. It has been demonstrated that some miRNAs have a key role in inflammatory response of monocyte-macrophages, such as miR-155, miR-146a, and miR-223 [11, 12] . In addition, the role of miRNAs in the pathogenesis of IVD has been reported in previous studies [13] . It has been suggested that the expression of miR-194 in cord blood granulocytes of newborn infants was downregulated after LPS induction, which indicates the role of miR-194 in the LPS-stimulated TLR signaling pathway [14] . Another study reported that miR-194 can regulate the palmitic acid-induced TLR4 inflammatory response via targeting TNF receptor-associated factor 6 (TRAF6) in human THP-1 cells [14] . Furthermore, miR-194 is able to regulate the LPS-induced NF-kB signal by mediating TLR4 expression. Collectively, miR-194 is an important miRNA involved in LPSinduced inflammatory responses. However, the role of miR-194 in IDD has not been reported.
In the present study, we aimed to explore the role of miR-194 in LPS-induced inflammatory responses in NP cells and to investigate its regulatory mechanism.
Material and Methods

Cell extraction and culture
Sprague-Dawley (SD) rats aged 6 weeks were purchased from the Experimental Animal Center of Shanghai (Shanghai, China). Animal experiments were approved by the Ethics Committee of Yantai YEDA Hospital. Under sterile conditions, the rat lumber vertebrae were extracted using scalpels, and NP was extracted under a microscope. The NP was washed 3 times, digested with trypsin and collagenase II in turn for 30 min and 3 h, respectively, then filtered with a 100-um filter screen and centrifuged for 5 min at 2000 rpm. NP cells were separated and collected, and cultured to passage 2-3 by DMEM complete medium supplemented with 10% fetal bovine serum (FBS) (SigmaAldrich Chemical Company, St Louis MO, USA), 100 U/ml penicillin (Sigma-Aldrich Chemical Company, St Louis MO, USA), and 100 mg/ml streptomycin (Sigma-Aldrich Chemical Company, St Louis MO, USA). first-strand cDNA using the First-Strand cDNA Synthesis Kit (Takara Biotechnology Ltd., Dalian, China). To determine the miR-194 expression, synthetase of the First-Strand cDNA Synthesis Kit (Takara Biotechnology Ltd., Dalian, China) was combined with specific reverse transcription primers of miR-194 to generate cDNA of miRNA. The q-PCR was applied to determine gene expression by using the SYBR Premix Ex Taq kit (Takara Biotechnology Ltd., Dalian, China) and ABI Prism 7500 Fast Real-Time PCR system (Applied Biosystems, Grand Island, NY, USA). The experiment was preformed strictly according to the kit instructions. Each reaction system contained: 10 μL SYBR Premix Ex Taq, 0.4 μL 10 μM downstream primers, 0.4 μL 10 μM upstream primers, 2 μL templates, and 7.2 μL sterile solution. For the determination of gene expression, the reaction procedure was: pre-denaturation at 95°C for 30 s and 40 cycles of 95°C for 3 s, and 60°C for 30 s. For the determination of miR-194, the reaction procedure was: pre-denaturation at 95°C for 10 min; denaturation at 95°C for 15 s, annealing at 60°C for 1 min, and extension at 72°C for 2 min (40 cycles). Gene expression level was calculated by 2 -DDct method. b-actin and U6 were used as the internal references. All primer sequences are shown in Supplementary Table 1.
ELISA determination
Expression levels of ECM degrading enzymes and inflammatory cytokines-associated genes were measured by use of an ELISA regent kit (R&D Systems, Minneapolis, MN, USA). The experiment was carried out strictly according to the kit instructions.
Western blotting
The obtained NP cells were washed 2-3 times with cold phosphate-buffered saline (PBS) (Sigma-Aldrich, St. Louis, MO, USA), and then lysed with RIPA lysis buffer (Sigma-Aldrich, St. Louis, MO, USA) to extract total protein. The concentration of the total protein was determined by use of a BCA kit (Thermo Fisher Scientific, San Jose, CA, US). A volume of 20 mg protein sample was drawn to the gel, separated by 10% SDS-PAGE, then transferred to polyvinylidene fluoride (PVDF) membranes (Millipore Corp., Bedford, MA, USA). The transfer membrane was sealed for 1 h with 5% skim milk at room temperature, washed once with PBS, and incubated overnight with primary antibodies at 4°C. The primary antibodies were as follows: antiAggrecan (ab36861 anti-GAPDH (ab9484, 1: 1000, Abcam, Cambridge, MA, USA). Following that, the transfer membrane was washed 3 times by TBST (TBS with Tween20) (Sigma-Aldrich, St. Louis, MO, USA). Secondary antibodies combined with HRP (ab131368, 1: 1000, Abcam, Cambridge, MA, USA) were incubated with the transfer membrane for 1 h. Protein bands were detected with an enhanced chemiluminescence assay kit (Thermo Fisher Scientific, San Jose, CA, USA). Images were captured using a ChemiDoc™ XRS + image analyzer (Bio-Rad Laboratories, Inc. CA, USA). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody served as the internal reference.
Luciferase assay TargetScanHuman 7.0 (http://www.targetscan.org/) and miRBase (http://www.mirbase.org/) microRNA databases were used to identify the target genes of miR-194. The primers of TRAF6 3'UTR and mutant TRAF6 3'UTR that may contain binding sites of miR-194 were amplified by PCR and then cloned into pMIR-REPORT Luciferase miR Expression Reporter Vector (Applied Biosystems, Grand Island, NY, USA), respectively. Then, the NP cells were transfected with the 2 types of vectors combined with Renilla vector (Promega Corp., Madison, Wisconsin, USA) and miR-194 mimics or negative controls, respectively. The luciferase was detected by use of luciferase reporter assay reagents (Promega Corp., Madison, Wisconsin, USA).
Determination of NF-kB activity
One day before the experiment, the NP cells transfected with miR-194 mimics or miR-194 inhibitor were placed into a 96-well plate at 1×10 4 cells/well. Co-transfection was performed by 
Statistical analysis
Data are expressed as the mean ± standard deviation. All data were processed using SPSS 20.0 software (SPSS, Inc., Chicago, IL, USA). One-way analysis of variance was performed for multiple comparisons, and differences discrepancies between 2 groups were compared using the unpaired t test for parametric data or the Mann-Whitney rank sum test for nonparametric data. P<0.05 was considered to indicate a statistically significant difference.
Results
MiR-194 was decreased in the LPS-induced NP cells
The NP cells were induced by 10 μg/ml LPS. The results demonstrated that miR-194 in the NP cells was significantly lower than that in the control group after 12 h, and was further reduced after 24 and 48 h compared with the control group (P<0.05; Figure 1A ).
Overexpressed miR-194 regulated the expression of ECM genes and synthesis of ECM-degrading enzymes
The experiments revealed that after LPS induction, the gene expression of Aggrecan and Collagen II was notably decreased in the NP cells in the LPS + scramble group, and transfection of miR-194 suppressed the down-regulation of LPS-induced Aggrecan and Collagen II (P<0.01; Figure 1B ). We used Western blotting to evaluate the protein levels of Aggrecan and Collagen II. The trend of the result was similar to that of q-PCR. As shown in Figure 1C , LPS induced Aggrecan and Collagen II protein down-expression, and miR-194 significantly reversed the decrease of Aggrecan and Collagen II.
To confirm the regulatory effect of miR-194 on the expression of ECM degrading enzymes (MMP3, MMP13, ADAMTS4, and ADAMTS5) in NP cells, the PCR and ELISA assays were used to measure the mRNA and protein levels, respectively, of various matrix-degrading enzymes. The results showed that the gene expression was significantly increased in the LPS + scramble 
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and LPS + miR-194 groups compared with the scramble group, and was remarkably inhibited in the miR-194 mimics group (P<0.01, P<0.001; Figure 1D , 1E). miR-194 significantly suppressed the increase of these degrading enzymes induced by LPS (P<0.001; Figure 1D , 1E).
Overexpressed miR-194 inhibited the expression of inflammatory cytokines-associated genes
To identify the regulatory effect of miR-194 on inflammatory cytokines-associated genes in LPS-induced NP cells, the expression of related genes was determined. The experiment showed 
MiR-194 inhibitor regulates the expression of inflammatory cytokines-associated genes
The expressions of inflammatory cytokines-associated genes of TNF-a, IL-1, IL-6, and PGE2 were detected by q-PCR. Through q-PCR assay, we found that the expression levels of these inflammatory cytokines-associated genes notably increased when cells were induced by LPS (P<0.001; Figure 4 ). As shown in Figure 4 , miR-194 inhibitor significantly promoted the gene expressions of TNF-a, IL-1, IL-6, and PGE2 in the LPS + miR-194 inhibitor group in contrast with those in the LPS + scramble group (P<0.05).
MiR-194 regulates TRAF6 expression
Through target prediction, we found that TRAF6 is a target gene of miR-194. It has been reported that TRAF6 is involved in cellular immunity and inflammatory responses [15, 16] . Therefore, we investigated whether miR-194 regulates TRAF6 expression Figure 5A , 5B). In contrast, miR-194 inhibitor led to an increase of TRAF6 expression (P<0.01; Figure 5C , 5D). These findings indicate that miR-194 exerts an inhibitory effect on TRAF6 expression.
To further assess the direct effect of miR-194 on TRAF6, we established a luciferase reporter plasmid of TRAF6 3' UTR sequence. The results showed that the TRAF6 3'UTR-mediated luciferase activity was significantly inhibited by miR-194 and it was significantly promoted by miR-194 inhibitor (P<0.01, P<0.001; Figure 5E , 5F). However, there was no significant difference in the mutant TRAF6 3'UTR-mediated luciferase activity.
MiR-194 regulates the inflammation in NP cells via NF-kB signaling pathway
TRAF6 plays a critical role in the ability of the TLR signal transduction pathway to activate NF-kB and mitogen-activated protein kinase (MAPK) pathways [17, 18] . Thus, the NP cells were transfected with luciferase reporter plasmid containing NF-kB responsive element, which further determined the regulatory effect of miR-194 on NF-kB transcriptional activity. The result showed that NF-kB-mediated luciferase activity was significantly inhibited by miR-194 and promoted by miR-194 inhibitor (P<0.01; Figure 6 ). 
Discussion
IDD is a common chronic disease in clinical practice. It burdens society clinically and economically due to its high rates of disability. About 10% of IDD patients have an obvious physical defect. Currently, relieving clinical symptoms is the main treatment for of IDD. However, biological therapy based on the pathological mechanism has become particularly popular in clinical research on IVD. In recent years, the role of miRNA has also 3064 become a focus in the progression of IDD. It has been demonstrated that miRNA is involved in IDD progression through multiple biological processes, mainly including: regulating the proliferation and apoptosis of NP cells [14, [19] [20] [21] , controlling the synthesis and dynamic balance of ECM [22, 23] , and mediating inflammatory responses [22] . Through exploring the function of miR-194 in NP cells, the present study adds to the theoretical basis for use of miRNA in the treatment of IDD.
In this study, we found that the expression of miR- Recent research found that inflammatory factors matrix metalloproteinases (MMPs) and ADAMTS-4\ADAMTS-5, which are associated with IDD, were all involved in the NF-kB signaling pathway because they are common target genes of NF-kB [21, 24] . NF-kB activation by endogenous or exogenous stimuli through cell antigen leads to NF-kB nuclear translocation, which can elevate the expression of inflammatory factors (such as IL-1/IL-6), MMPs, and ADAMTS. Based on these reports, the present study explored the relationship between miR-194 and NF-kB. Our investigation found that the activity of NF-kB luciferase was inhibited by miR-194 overexpression but promoted by miR-194 inhibitor, which suggests that the regulatory function of miR-194 operates via the NF-kB signaling pathway. Combined with prior conclusions, we conclude that miR-194 regulates the inflammatory responses in LPSinduced NP cells by regulating the NF-kB signaling pathway.
To explore the anti-inflammatory mechanism of miR-194 in NP cells, we used 2 algorithm programs (TargetScan and miRBase) to search for the potential targets of miR-194. We found that TRAF6 is a target of miR-194. In NF-kB pathway stimulated by LPS, activated TRAF6 induced phosphorylation and degradation of NF-kB inhibitor, I kappa B (IkB), further leading to the release of NF-kB from IkB/NF-kB trimer, ultimately activating nuclear factor NF-kB and inducing the expression of inflammatory factors such as TNF-N and IL-1 in some cells [25, 26] . Our experimental results demonstrate that miR-194 overexpression downregulates the activity of TRAF6 3' UTR-mediated luciferase, which is contrary to the effect of miR-194 inhibitor. Notably, both miR-194 overexpression and miR-194 inhibitor have no significant effect on the mutant TRAF6 3'UTR-mediated luciferase activity. Therefore, miR-194 exerts its regulatory function on inflammatory responses of LPS-induced NP cells by targeting TRAF6.
Conclusions
In conclusion, miR-194 inhibits activation of the NF-kB signaling pathway by targeting TRAF6, leading to suppression of the LPS-induced inflammatory responses in NP cells (Figure 8) , showing it may be a regulatory mechanism in IDD.
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